source
- Telehealth firms Hims & Hers and Noom launch prescription peptide programs after HHS rule changeTelehealth companies Hims & Hers and Noom announced this week that they will begin prescribing peptide products to eligible patients, marking the first major consumer‑focused rollouts of such thera…
- Drugmakers urged to assess device capabilities and engage regulators early for combo productsAt the AFDO/RAPS Combination Products Summit, a panel of experts advised drugmakers that developing standalone medical devices to be used with their drugs requires careful evaluation of the devices…